cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.

Alveolar rhabdomyosarcoma is an aggressive pediatric cancer of striated muscle characterized in 60% of cases by a t(2;13)(q35;q14). This results in the fusion of PAX3, a developmental transcription factor required for limb myogenesis, with FKHR, a member of the forkhead family of transcription factors. The resultant PAX3-FKHR gene possesses transforming properties; however, the effects of this chimeric oncogene on gene expression are largely unknown. To investigate the actions of these transcription factors, both Pax3 and PAX3-FKHR were introduced into NIH 3T3 cells, and the resultant gene expression changes were analyzed with a murine cDNA microarray containing 2,225 elements. We found that PAX3-FKHR but not PAX3 activated a myogenic transcription program including the induction of transcription factors MyoD, Myogenin, Six1, and Slug as well as a battery of genes involved in several aspects of muscle function. Notable among this group were the growth factor gene Igf2 and its binding protein Igfbp5. Relevance of this model was suggested by verification that three of these genes (IGFBP5, HSIX1, and Slug) were also expressed in alveolar rhabdomyosarcoma cell lines. This study utilizes cDNA microarrays to elucidate the pattern of gene expression induced by an oncogenic transcription factor and demonstrates the profound myogenic properties of PAX3-FKHR in NIH 3T3 cells.

[1]  H. Snodgrass,et al.  Cloning and developmental expression analysis of the murine c-mer tyrosine kinase. , 1995, Oncogene.

[2]  J. Moore,et al.  Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. , 1998, Cancer Research.

[3]  B. Schäfer,et al.  Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes. , 1994, Nucleic acids research.

[4]  V. Hartenstein,et al.  Homeobox genes and connective tissue patterning. , 1995, Development.

[5]  T. Wood,et al.  Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. , 1994, Endocrinology.

[6]  P. Brown,et al.  A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. , 1996, Genome research.

[7]  M. Bittner,et al.  Expression profiling in cancer using cDNA microarrays , 1999, Electrophoresis.

[8]  E. Kohn,et al.  Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[9]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[10]  F. Barr,et al.  Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Downing,et al.  Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. , 1993, Cancer research.

[12]  P. Gasque,et al.  Human skeletal myoblasts spontaneously activate allogeneic complement but are resistant to killing. , 1996, Journal of immunology.

[13]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[14]  D G Wilkinson,et al.  Control of cell behavior during vertebrate development by Slug, a zinc finger gene. , 1994, Science.

[15]  C. Glass,et al.  Human fetal muscle and cultured myotubes derived from it contain a fetal-specific myosin light chain. , 1983, Science.

[16]  F. Barr.  Translocations, cancer and the puzzle of specificity , 1998, Nature Genetics.

[17]  P. Ferretti,et al.  Expression of the transcription factor slug correlates with growth of the limb bud and is regulated by FGF-4 and retinoic acid. , 1997, The International journal of developmental biology.

[18]  J. Epstein,et al.  Pax3 modulates expression of the c-Met receptor during limb muscle development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Epstein,et al.  Tumor-Specific PAX3-FKHR Transcription Factor, but Not PAX3, Activates the Platelet-Derived Growth Factor Alpha Receptor , 1998, Molecular and Cellular Biology.

[20]  H. Ford,et al.  Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Gruss,et al.  Pax3: A paired domain gene as a regulator in PNS myelination , 1995, Neuron.

[22]  R. Davis,et al.  Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma. , 1998, Cancer research.

[23]  P. Vogt,et al.  The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Barr,et al.  Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. , 1995, Oncogene.

[25]  G. Grosveld,et al.  The Pax3–FKHR oncoprotein is unresponsive to the Pax3‐associated repressor hDaxx , 1999, The EMBO journal.

[26]  M. Roussel,et al.  The Oncogenic Potential of the Pax3-FKHR Fusion Protein Requires the Pax3 Homeodomain Recognition Helix but Not the Pax3 Paired-Box DNA Binding Domain , 1999, Molecular and Cellular Biology.

[27]  B. Emanuel,et al.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.

[28]  M. Siciliano,et al.  Cloning of the human SIX1 gene and its assignment to chromosome 14. , 1996, Genomics.

[29]  M. Bartolomei,et al.  Parental imprinting of the mouse H19 gene , 1991, Nature.

[30]  E. Jabs,et al.  Human SLUG gene organization, expression, and chromosome map location on 8q. , 1998, Genomics.

[31]  R. Davis,et al.  Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Braun,et al.  Expression of members of the myf gene family in human rhabdomyosarcomas. , 1991, British Journal of Cancer.

[33]  J. Biegel,et al.  In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. , 1996, Human molecular genetics.

[34]  P. Rotwein,et al.  Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. , 1995, Molecular endocrinology.

[35]  E. Olson,et al.  MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. , 1992, Development.

[36]  H. Arnold,et al.  Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. , 1994, Development.

[37]  F. Barr,et al.  The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3 , 1995, Molecular and cellular biology.

[38]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[39]  J. Concordet,et al.  Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Epstein,et al.  Pax3 Inhibits Myogenic Differentiation of Cultured Myoblast Cells (*) , 1995, The Journal of Biological Chemistry.